14-day Premium Trial Subscription Try For FreeTry Free
BioTelemetry (BEAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioTelemetry (NASDAQ:BEAT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm currently has a $46.00
Those holding BioTelemetry (NASDAQ:BEAT) shares must be pleased that the share price has rebounded 37% in the last...
Exchange Traded Concepts LLC lifted its stake in shares of BioTelemetry Inc (NASDAQ:BEAT) by 90.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities an

Hedge Funds Are Betting On KEMET Corporation (KEM)

04:29pm, Wednesday, 15'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Hedge Funds Are Selling BioTelemetry, Inc. (BEAT)

04:28pm, Wednesday, 15'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Geode Capital Management LLC boosted its stake in BioTelemetry Inc (NASDAQ:BEAT) by 3.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional i
Ladenburg Thalmann Financial Services Inc. decreased its position in shares of BioTelemetry Inc (NASDAQ:BEAT) by 7.0% in the 4th quarter, according to the company in its most recent Form 13F filing wi
Anyone researching BioTelemetry, Inc. (NASDAQ:BEAT) might want to consider the historical volatility of the share...
Piano van: Hong Kong music lessons go mobile to beat virus
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Reilly Financial Advisors LLC purchased a new stake in BioTelemetry Inc (NASDAQ:BEAT) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The insti
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE